Cargando…
Molecular detection of rifampin and isoniazid resistance to guide chronic TB patient management in Burkina Faso
BACKGROUND: Drug-resistant tuberculosis (DR-TB) is considered a real threat to the achievement of TB control. Testing of mycobacterial culture and testing of drug susceptibility (DST) capacity are limited in resource-poor countries, therefore inadequate treatment may occur, favouring resistance deve...
Autores principales: | Miotto, Paolo, Saleri, Nuccia, Dembelé, Mathurin, Ouedraogo, Martial, Badoum, Gisèle, Pinsi, Gabriele, Migliori, Giovanni B, Matteelli, Alberto, Cirillo, Daniela M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2739213/ https://www.ncbi.nlm.nih.gov/pubmed/19715569 http://dx.doi.org/10.1186/1471-2334-9-142 |
Ejemplares similares
-
Extensively Drug-Resistant Tuberculosis, Burkina Faso
por: Saleri, Nuccia, et al.
Publicado: (2010) -
Mycobacterium sherrisii Pulmonary Disease, Burkina Faso
por: Borroni, Emanuele, et al.
Publicado: (2015) -
Prevalence of symptoms of sleep apnoea syndrome in Burkina Faso
por: Ouédraogo, G, et al.
Publicado: (2019) -
Prevalence of obstructive sleep apnoea in sleep consultations in Burkina Faso: Implications for monitoring
por: Ouédraogo, A R, et al.
Publicado: (2020) -
Multidrug-Resistant Tuberculosis in Burkina Faso from 2006 to 2017: Results of National Surveys
por: Diandé, Souba, et al.
Publicado: (2019)